梅花生物：2025年半年度净利润约17.68亿元，同比增加19.96%

Core Viewpoint - Meihua Biological reported a slight decrease in revenue for the first half of 2025, while net profit and earnings per share showed significant growth [2] Financial Performance - The company's revenue for the first half of 2025 was approximately 12.28 billion yuan, representing a year-on-year decrease of 2.87% [2] - Net profit attributable to shareholders was around 1.768 billion yuan, reflecting a year-on-year increase of 19.96% [2] - Basic earnings per share increased to 0.62 yuan, up 24% compared to the previous year [2]